Amita de Souza
Pediatric Endocrinology · N Bethesda, MDNPI 1912296492
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Novo Nordisk at 24.1% of the total. Reporting peaked in 2022 at $594 and has fallen 50.1% since, to $296 in 2025.
Across 126 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$727
- Emergent Biosolutions Inc.$340
- Corium, LLC$251
- Tris Pharma Inc$246
- Ascendis Pharma Endocrinology Inc$179
- Tolmar, Inc.$124
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,00099%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 38 | $727 |
| Emergent Biosolutions Inc. | 1 | $340 |
| Corium, LLC | 8 | $251 |
| Tris Pharma Inc | 9 | $246 |
| Ascendis Pharma Endocrinology Inc | 10 | $179 |
| Tolmar, Inc. | 6 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Kaleo, Inc. | 5 | $106 |
| GSK | 4 | $104 |
| Cranial Technologies, Inc | 8 | $88 |
| AbbVie | 3 | $79 |
| Ironshore Pharmaceuticals Inc. | 4 | $77 |
| Tolmar Pharmaceuticals, Inc. | 3 | $67 |
| Merck | 3 | $63 |
| Pfizer | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Endo Pharmaceuticals Inc. | 2 | $47 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| AstraZeneca(2 entities) | 2 | $41 |
| Sandoz | 2 | $36 |
| Rhythm Pharmaceuticals, Inc. | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Sobi, Inc | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,015 in reported general payments places this provider in the 70th percentile of 33 pediatric endocrinology providers in Maryland.
Other pediatric endocrinology in N Bethesda
- Maya LodishBethesda$34K
- Barry ReinerBaltimore$15K
- David CookeBaltimore$8K
- Risa WolfBaltimore$7K
- Mary RobertsBethesda$6K
- Ryan MillerBaltimore$5K
- Robert KritzlerLutherville$5K
- Cong NingRockville$4K
- Sandra SalsbergBaltimore$3K
- Noelle LarsonBethesda$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.